Syringes with retractable needles can have the advantage of moving the needle out from exposure once the injection has been performed, potentially presenting a particular interest for disposal, or otherwise for use by persons who do not have a profound medical training. International patent application publication WO2014096957 presents various embodiments of syringes with retractable needles.
While existing technology was found satisfactory to a certain extent, there remained room for improvement.
In accordance with one aspect, there is provided a syringe having a plunger body and a plunger seal both independently slidingly engaged within a cavity of a barrel for movement along a common longitudinal axis, and a needle anchored to the plunger body and extending across the plunger seal, the needle having an inlet aperture allowing fluid flow communication into an internal conduit of the needle, the barrel having a reservoir for receiving a medical fluid, the reservoir extending between the plunger seal and a bottom, the bottom being closed by a septum, wherein to proceed with injection, the plunger body is slid toward the plunger seal along a penetration span, during which movement the needle punctures the septum and protrudes from the bottom without injecting medical fluid, until the plunger body engages the plunger seal, after which the plunger body and the plunger seal are collectively moved to inject the medical fluid until the plunger seal reaches the bottom.
In accordance with another aspect, there is provided a syringe having a plunger having a plunger seal slidingly engaged within a cavity of a barrel, and a needle anchored to the plunger, the barrel having a reservoir for receiving a medical fluid, the reservoir extending between the plunger seal and a bottom, the bottom being closed by a septum, the needle having a lateral aperture allowing fluid flow communication between the reservoir and an internal conduit of the needle, wherein to proceed with injection, the plunger seal and the anchored needle are collectively moved along an axis of the syringe toward the bottom to inject the medical fluid until the plunger seal reaches the bottom, wherein the lateral aperture of the needle extends along a given axial length immediately below the plunger seal in a manner remain exposed to the reservoir until the plunger seal has reached the bottom.
In accordance with another aspect, there is provided a syringe having a plunger anchor to which a needle is anchored and a plunger seal both slidingly engaged within a cavity of a barrel, and a plunger actuator having at least two elastic arms slidingly engaged around the barrel, the arms being biased to a radially inward position and prevented by the barrel, the barrel having a septum seal at a bottom and an open top, wherein to proceed with injection, the plunger actuator is pulled upwardly until the arms are freed from the barrel, at which points the arms are freed and move to the radially inward position, and the plunger actuator can be pushed downwardly to engage the arms into the barrel via the open top, until they engage the plunger anchor and become operable to push the needle across the septum.
Many further features and combinations thereof concerning the present improvements will appear to those skilled in the art following a reading of the instant disclosure.
In the figures,
The figures show syringes with a confined needle, a reservoir with a prefilled medical fluid, and a plunger to which the needle is anchored. The plunger is in two parts: a body and a seal.
A first embodiment of a syringe is shown in
To proceed to injection, the second end 30 of the barrel 10, and the septum 26, are positioned against the skin of the patient. The plunger body 14 is then activated to move along the longitudinal axis of displacement, moving the anchored needle 18 with it. The plunger body 14 will first advance along a penetration span 32 corresponding to the longitudinal length of the spacing 24, and the free end of the needle 18 will pierce the septum 26 and penetrate into the body of the patient. During this movement, medical fluid is free to move into the cylindrical recess, across the inlet 22, and be injected into the patient. However, the volume of the reservoir 22 remains the same during this movement, and fluid is not pushed across the needle aperture 22 and into the patient until the plunger body 14 engages the plunger seal 16 in the configuration shown in
In an alternate embodiment, the internal needle conduit is filled with medical fluid in the initial position, but the plunger seal 16 does not have a cylindrical recess and rather abuts against the needle inlet 22 and an additional portion of the needle under the needle inlet, in a manner that the needle inlet 22 is sealed by the plunger seal 16 and remains sealed by the plunger seal as the plunger body 14 is moved along the penetration distance. The needle inlet 22 only becomes exposed to the reservoir 12 once the plunger body 14 has been moved along the penetration span 32 and needle inlet 22 has crossed the plunger seal 16.
Referring now to
It will be noted here that in the position shown in
From that position, the movement of the plunger body 14 is reversed, pulling the needle 18 back into the reservoir 12 (not shown). During the reversed movement, the friction between the plunger seal 16 and the barrel 10 is greater than the friction between the plunger seal 16 and the needle 18, and the plunger seal 16 will typically remain in its fully deployed position as the needle 18 is retracted. Once the needle aperture 22 has moved across the plunger seal 16 and is exposed to the atmosphere, the internal needle conduit remains at atmospheric pressure.
It will be noted that the reservoir 112 generally has a cylindrical shape in this embodiment. The exact volume of a specific design which departs from a cylindrical shape can be calculated using a computer assisted drawing software, for instance. Nonetheless, to evaluate the general principles, we will look into an example cylindrical shape. A cylindrical volume can be calculated by the equation V=πr2h where r is the radius and h is the height. In this example, it will be understood that the reservoir can be designed in a manner for the injecting action of a given volume of medical fluid to be confined within a given height span of the reservoir. Indeed, this can be achieved by adapting the radius r of the reservoir accordingly. A reservoir having a larger radius, for a given volume, can be used for sub-cutaneous injection, whereas a reservoir having a smaller radius and a greater height, for a given volume, can be used for intramuscular injection, for instance. The penetration span 132 can be adjusted independently from the injection span 134 as can be understood from the above. The design shown in
An example of a design adapted for intra-muscular injection is shown in
It will be understood that embodiments of the syringe can be provide with an automatically retracting feature which biases the plunger body to the retracted position in a manner that once the injection has been completed, the plunger body can be activated to move to its fully retracted position in the absence of an external force (e.g. when the volume-confining force applied by the user to proceed with injection has been discontinued).
An example of a syringe 311 having an automatic retraction feature is provided in
Still another example of a syringe is provided in
Pre-Clinical Trial
A preliminary pre-clinical trial was performed to assess the functionality a syringe which displaces the needle tip more deeply into the body as the medical fluid is being injected. More specifically, the trial was performed using a syringe such as shown in
Two ˜10 kg Landrace Yorkshire Cross pigs received Intra Muscular (IM) injections of 500 μL of India ink in marked locations. Three injections were performed with a standard 1 cc tuberculin syringe (AIM) and 3 injections were performed with a syringe with a retractable needle which was fixedly mounted to the plunger (BIM). One animal was sacrificed at an early (E) time point (t=1 hour), the other was sacrificed at a later (L) time point (t=5 hours). The injections sites were evaluated on a standard scoring system with high quality digital pictures taken at a fixed distance for digital analysis. The injection sites were then excised for histological evaluation. The external injection site evaluation demonstrated that all injection sites were normal. Table 1, below, presents the mean summary data sheet for the excised injection site evaluation.
In the test sample sacrificed at the later time point, the mean volume of injection was significantly higher for the syringe with the retractable needle than for the standard 1 cc tuberculin syringe.
In this description, specific embodiments are described with reference to associated figures for the purpose of providing example ways of embodying the invention(s). The invention(s) is/are not to be construed as being limited in scope to the specific embodiments described.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/CA2016/051481 | 12/15/2016 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62267351 | Dec 2015 | US |